Sushil Patel has sold stock and made no open-market buys since May 2022

Sushil Patel, Ph.D., is a Person and the Chief Executive Officer of Replimune Group, Inc. since April 2024.( He joined Replimune in 2021 as Chief Commercial Officer and later served as Chief Strategy Officer before being elevated to CEO.(

Dr. Patel has more than 20 years of biotech and oncology experience, with a career focused on commercialization strategy, launch execution, and global oncology marketing and sales. Before Replimune, he was franchise head for lung, skin, tumor agnostic, and rare cancers at Genentech, and earlier held roles in strategic management consulting and at IMS Health.( He has been involved in more than eight product launches across marketing, sales, and franchise management, and holds a Ph.D. in Molecular Biology from the University of London, an M.S. in Biotechnology from Imperial College London, and a B.S. in Microbiology and Microbial Technology from the University of Warwick.(

Written by Perplexity from public sources.